Systemic Regulatory Abnormalities in Glycemic Control and its Relation with Depression - A Cross-Sectional Study

Aravindh M; Shabeeba Z Kailash; Kailash Sureshkumar

doi:10.52756/ijerr.2024.v40spl.013

Authors

Aravindh M Department of Psychiatry, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam - 603103, Tamil Nadu, India https://orcid.org/0009-0004-8517-4305
Shabeeba Z Kailash Department of Psychiatry, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam - 603103, Tamil Nadu, India https://orcid.org/0000-0002-6764-0892
Kailash Sureshkumar Department of Psychiatry, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam - 603103, Tamil Nadu, India https://orcid.org/0000-0002-3922-2343

DOI:

https://doi.org/10.52756/ijerr.2024.v40spl.013

Keywords:

Depression, Glycemic index, Depression severity, Type 2 Diabetes Mellitus

Abstract

Globally, depression is the 3rd leading cause of disability-adjusted life years. The presence of depression and its symptoms has been associated with improper control of glucose and poor glycemic index and a bidirectional relationship was seen between depressive disorders and diabetes mellitus. Depression, even at subclinical levels, has the tendency to increase the risk of incident type 2 diabetes by 25–60%. This study aims to find the prevalence of Type 2 diabetes mellitus(T2DM) in depression patients and to find the relationship between the severity of depression and the severity of T2DM in a Cross-sectional study. A total of 178 patients who attended psychiatry OPD of a tertiary healthcare hospital for a study period of 6 months were recruited into the study after considering inclusion and exclusion criteria evaluated by an experienced psychiatrist. Details like sociodemographic profiles and clinical data related to Major depression and T2DM were collected through self-structured proforma. To assess the severity of depression, HAM-D scale was used and the glycemic severity measure was used to assess the severity of T2DM by a well-trained psychiatrist. Statistical analysis was done and results were framed. The prevalence of Type 2 Diabetes mellitus in depressive disorder patients was found to be 25.2%. A significant association was seen between the severity of T2DM and the severity of depression, with a p-value of 0.013 and a chi-square value of 12.699. Significance with certain clinical factors like insulin usage (F=5.635; p = 0.019) and drug compliance (F=16.841; p <0.001) was seen in T2DM patients with depression. Nearly ¼^th of the patients with depression had T2DM and the severity of hyperglycaemia was also found to be high as those patients were on insulin administration, other medical comorbidity disorders were present and drug compliance was found to be poor. Triglyceride glucose index was also found to be high in patients with severe depression, which contributes to improper blood glucose balance. Treating and reducing both the severity of T2DM and depression simultaneously is needed to improve the functioning of the patients and improve the retention in treatment and drug compliance, thereby preventing morbidity and mortality.

References

Acharya, C.K., Das, B., Madhu, N.R., Sau, S., Manna De, M., & Sarkar, B. (2023). A Comprehensive Pharmacological Appraisal of Indian Traditional Medicinal Plants with Anti-diabetic Potential. Springer Nature Singapore Pte Ltd., Advances in Diabetes Research and Management, pp. 163–193, Online ISBN-978-981-19-0027-3. https://doi.org/10.1007/978-981-19-0027-3_8

Anwar, N., Kuppili, P. P., & Balhara, Y. P. S. (2017). Depression and physical noncommunicable diseases: The need for an integrated approach. WHO South East Asia J Public Health, 6(1), 12-17. https://doi.org/10.4103/2224-3151.206158.

Basiri, R., Seidu, B., & Rudich, M. (2023). Exploring the Interrelationships between Diabetes, Nutrition, Anxiety, and Depression: Implications for Treatment and Prevention Strategies. Nutrients, 15(19), 4226. https://doi.org/10.3390/nu15194226.

Bhattacharjee, P., & Manna, C. (2016). Potential plants as nervine for Unani system of medicine from the Coochbehar district, West Bengal, India. International Journal of Experimental Research and Review, 5, 19-24. https://qtanalytics.in/journals/index.php/IJERR/article/view/1329.

Biswas, T., Behera, B. K., & Madhu, N.R. (2023). Technology in the Management of Type 1 and Type 2 Diabetes Mellitus: Recent Status and Future Prospects. 26 pages, Springer Nature Singapore Pte Ltd., Advances in Diabetes Research and Management. pp. 111–136. Online ISBN-978-981-19-0027-3. https://doi.org/10.1007/978-981-19-0027-3_6

Bonful, H.A., & Anum, A. (2019). Sociodemographic correlates of depressive symptoms: a cross-sectional analytic study among healthy urban Ghanaian women. BMC Public Health, 19, 50. https://doi.org/10.1186/s12889-018-6322-8.

Campayo, A., de Jonge, P., Roy, J. F., Saz, P., de la Cámara, C., Quintanilla, M. A., Marcos, G., Santabárbara, J., & Lobo, A., & ZARADEMP Project. (2010). Depressive disorder and incident diabetes mellitus: the effect of characteristics of depression. Am J Psychiatry, 167(5), 580-8. https://doi.org/10.1176/appi.ajp.2009.09010038.

Chellaiyan, V. G., Jenniferbritto, J., & Alfred, J. (2022). Impact of Digital Health Education among Patients with Type 2 Diabetes Mellitus. National Journal of Community Medicine, 13(03), 171-174. https://doi.org/10.55489/njcm.1332022394.

Cheng, G., Huang, C., Deng, H., & Wang, H. (2012). Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Internal Medicine Journal, 42(5), 484–491. https://doi.org/10.1111/j.1445-5994.2012.02758.x.

Correia, A. S., Cardoso, A., & Vale, N. (2023). Oxidative Stress in Depression: The Link with the Stress Response, Neuroinflammation, Serotonin, Neurogenesis and Synaptic Plasticity. Antioxidants, 12(2), 470. https://doi.org/10.3390/antiox12020470.

Crispín-Trebejo, B., Robles-Cuadros, M. C., & Bernabé-Ortiz, A. (2015 ). Association between depression and glycemic control among type 2 diabetes patients in Lima, Peru. Asia Pac Psychiatry, 7(4), 419-26. https://doi.org/10.1111/appy.12190.

Cummings, D. M., Kirian, K., Howard, G., Howard, V., Yuan, Y., Muntner, P., Kissela, B., Redmond, N., Judd, S. E., & Safford, M. M. (2016). Consequences of Comorbidity of Elevated Stress and/or Depressive Symptoms and Incident Cardiovascular Outcomes in Diabetes: Results From the REasons for Geographic And Racial Differences in Stroke (REGARDS) Study. Diabetes care, 39(1), 101–109. https://doi.org/10.2337/dc15-1174.

Demakakos, P., Pierce, M. B., & Hardy, R. (2010). Depressive symptoms and risk of type 2 diabetes in a national sample of middle-aged and older adults: the English longitudinal study of ageing. Diabetes Care, 33(4), 792-7. https://doi.org/10.2337/dc09-1663.

Egede, L. E., Nietert, P. J., & Zheng, D. (2005).Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care, 28(6), 1339-45. https://doi.org/10.2337/diacare.28.6.1339.

Engidaw, N.A., Wubetu, A.D., & Basha, E.A.(2020). Prevalence of depression and its associated factors among patients with diabetes mellitus at Tirunesh-Beijing General Hospital, Addis Ababa, Ethiopia. BMC Public Health, 20, 266. https://doi.org/10.1186/s12889-020-8360-2.

Frank, P., Batty, G. D., & Pentti, J.(2023). Association Between Depression and Physical Conditions Requiring Hospitalization. JAMA Psychiatry, 80(7), 690–699. https://doi.org/10.1001/jamapsychiatry.2023.0777.

Goldston, D. B., Kovacs, M., Ho, V. Y., Parrone, P. L., & Stiffler, L. (1994). Suicidal ideation and suicide attempts among youth with insulin-dependent diabetes mellitus. Journal of the American Academy of Child and Adolescent Psychiatry, 33(2), 240–246. https://doi.org/10.1097/00004583-199402000.

Gonzalez, J. S., Peyrot, M., McCarl, L. A., Collins, E. M., Serpa, L., & Mimiaga, M. J. (2008). Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care, 31(12), 2398-403. https://doi.org/10.2337/dc08-1341.

Hamilton, M. (1967). Development of a rating scale; for primary depressive illness. Br. J. Soc. Clin. Psychol. https://pubmed.ncbi.nlm.nih.gov/6080235/. https://doi.org/10.1001/jamapsychiatry.2013.1965.

Ilamathi, K.R., Aditi, R., Daya, A., Praveena., Ramkumar, M., & Umeshkumar, P.M. (2023). Association between Type of Diet, Extent of Sweet Consumption and Status of Physical Activity with Presence of Type II Diabetes Mellitus. International Journal of Nutrition, Pharmacology, Neurological Diseases, 13(1), 40-46. https://doi.org/10.4103/ijnpnd.ijnpnd_54_22.

Kulkarni, V., Chinnakali, P., Kanchan, T., Rao, A., Shenoy, M., & Papanna, M. K. (2014). Psychiatric Co-morbidities among Patients with Select Non-communicable Diseases in a Coastal City of South India. International Journal of Preventive Medicine, 5(9), 1139–1145.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192776/.

Li, S., Yang, D., Zhou, X., Chen, L., Liu, L., & Lin, R. (2024). Neurological and metabolic related pathophysiologies and treatment of comorbid diabetes with depression. CNS Neuroscience & Therapeutics, 30(4), e14497. https://doi.org/10.1111/cns.14497.

Li, W., Ruan, W., Peng, Y., Lu, Z., & Wang, D. (2021).Associations of socioeconomic status and sleep disorder with depression among US adults. J. Affect Disord, 1, 295, 21-27. https://doi.org/10.1016/j.jad.2021.08.009.

Madhavudu, M. V., Divya, N., Ranganathan, P., P.G., M. K., P.V., H. H. S., Subramanian., & S. sundaram. (2023). Determining the Predominant Risk Factor of Low Back Pain Among Pre-Menopausal and Post-Menopausal Women. International Journal of Experimental Research and Review, 34(Special Vol.), 36-43. https://doi.org/10.52756/ijerr.2023.v34spl.005.

Maina, J. G., Balkhiyarova, Z., Nouwen, A., Pupko, I., Ulrich, A., & Boissel, M. (2023). Bidirectional Mendelian Randomization and Multiphenotype GWAS Show Causality and Shared Pathophysiology Between Depression and Type 2 Diabetes. Diabetes care, 46(9), 1707–1714. https://doi.org/10.2337/dc22-2373.

Majhi, M. M., & Bhatnagar, N. (2021). Updated B.G Prasad's classification for the year 2021: consideration for new base year 2016. Journal of Family Medicine and Primary Care, 10(11), 4318–4319. https://doi.org/10.4103/jfmpc.jfmpc_987_21.

Mary de Groot (2023). Diabetes and Depression: Strategies to Address a Common Comorbidity Within the Primary Care Context, American Journal of Medicine Open, 9, 100039, https://doi.org/10.1016/j.ajmo.2023.100039.

Mezuk, B., Eaton, W. W., Albrecht, S., & Golden S. H.(2008). Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care, 31(12), 2383-90. https://doi.org/10.2337/dc08-0985.

Mori, T., Nagata, T., Nagata, M., Fujimoto, K., Fujino, Y., & Mori, K. (2021). Diabetes severity measured by treatment control status and number of anti-diabetic drugs affects presenteeism among workers with type 2 diabetes. BMC Public Health, 21(1), 1865. https://doi.org/10.1186/s12889-021-11913-3.

Mukeshimana, M., & Chironda, G. (2019). Depression and Associated Factors Among the Patients with Type 2 Diabetes in Rwanda. Ethiop J. Health Sci., 29(6), 709-718. https://doi.org/10.4314/ejhs.v29i6.7.

OuYang, H., Chen, B., Abdulrahman, A. M., Li, L., & Wu, N. (2021). Associations between Gestational Diabetes and Anxiety or Depression: A Systematic Review. Journal of Diabetes Research, 9959779. https://doi.org/10.1155/2021/9959779.

Praveen, V., Preetha, G., Prabhakaran, R., Prabhushankar, J., & Sathiyapriya, V. (2020). Assessment of Level of Anxiety among Diabetes Mellitus Patients in Selected Tertiary Hospital in Kelambakkam, Kanchipuram District, Tamil Nadu, India. Medico-legal Update, 20(2). https://doi.org/10.37506/mlu.v20i2.1085.

Rotella, F., & Mannucci, E. (2013). Depression as a risk factor for diabetes: a meta-analysis of longitudinal studies. The Journal of Clinical Psychiatry, 74(1), 31–37. https://doi.org/10.4088/JCP.12r07922.

Roy, R., Chakraborty, A., Jana, K., Sarkar, B., Biswas, P., & Madhu, N.R. (2023). The Broader Aspects of Treating Diabetes with the Application of Nanobiotechnology. Springer Nature Singapore Pte Ltd., Advances in Diabetes Research and Management, pp. 137–162, Online ISBN-978-981-19-0027-3, https://doi.org/10.1007/978-981-19-0027-3_7

Salazar, J., Bermúdez, V., Calvo, M., Olivar, L. C., Luzardo, E., Navarro, C., Mencia, H., Martínez, M., Rivas-Ríos, J., Wilches-Durán, S., Cerda, M., Graterol, M., Graterol, R., Garicano, C., Hernández, J., & Rojas, J. (2017). Optimal cutoff for the evaluation of insulin resistance through triglyceride-glucose index: A cross-sectional study in a Venezuelan population. F1000Research, 6, 1337. https://doi.org/10.12688/f1000research.12170.3.

Sarkar, S., Sadhu, S., Roy, R., Tarafdar, S., Mukherjee, N., Sil, M., Goswami, A., & Madhu, N.R. (2023). Contemporary Drifts in Diabetes Management. Int. J. App. Pharm., 15(2), 1-9. https://doi.org/10.22159/ijap.2023v15i2.46792

Sarwar, N., Gao, P., & Seshasai, S. R. (2010). Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet (London, England), 375(9733), 2215–2222. https://doi.org/10.1016/S0140-6736(10)60484-9.

Shek, D. T. L. (1995). Gender differences in marital quality and well-being in Chinese married adults. Sex Roles, 32, 699–715. https://doi.org/10.1007/BF01560185.

Shi, Y. Y., Zheng, R., & Cai, J. J. (2021).The association between triglyceride glucose index and depression: data from NHANES 2005–2018. BMC Psychiatry, 21, 267. https://doi.org/10.1186/s12888-021-03275-2.

Sullivan, M. D., Katon, W. J., Lovato, L. C., Miller, M. E., Murray, A. M., & Horowitz (2013). Association of depression with accelerated cognitive decline among patients with type 2 diabetes in the ACCORD-MIND trial. JAMA Psychiatry, 70(10), 1041–1047.

Sur, T., Das, A., Bashar, S., Tarafdar, S., Sarkar, B., & Madhu, N.R. (2023). Biochemical Assay for Measuring Diabetes Mellitus. Springer Nature Singapore Pte Ltd., Advances in Diabetes Research and Management, pp. 1–20, Online ISBN-978-981-19-0027-3, https://doi.org/10.1007/978-981-19-0027-3_1

Van Sloten, T. T., Sedaghat, S., Carnethon, M. R., Launer, L. J., & Stehouwer, C. D. A. (2020). Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression. The lancet. Diabetes & Endocrinology, 8(4), 325–336. https://doi.org/10.1016/S2213-8587(19)30405-X.

Wang, X., Bao, W., Liu, J., Ouyang, Y. Y., Wang, D., & Rong, S. (2013). Inflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care, 36(1), 166-75. https://doi.org/10.2337/dc12-0702.